[1]赵崇山,王宁方.脾脏硬度联合流式细胞术在急性髓系白血病微小残留病监测中的意义[J].医学信息,2022,35(05):121-123.[doi:10.3969/j.issn.1006-1959.2022.05.031]
　ZHAO Chong-shan,WANG Ning-fang.The Significance of Spleen Stiffness Measurement Combine with Flow Cytometry in Acute Myeloid Leukemia Minimal Residual Disease[J].Medical Information,2022,35(05):121-123.[doi:10.3969/j.issn.1006-1959.2022.05.031]
点击复制

脾脏硬度联合流式细胞术在急性髓系白血病微小残留病监测中的意义()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年05期
页码:
121-123
栏目:
临床研究
出版日期:
2022-03-01

文章信息/Info

Title:
The Significance of Spleen Stiffness Measurement Combine with Flow Cytometry in Acute Myeloid Leukemia Minimal Residual Disease
文章编号:
1006-1959（2022）05-0121-03
作者:
赵崇山; 王宁方
（河北中石油中心医院感染科1，血液科2，河北 廊坊 065000）
Author(s):
ZHAO Chong-shan; WANG Ning-fang
(Department of Infectious Diseases1,Department of Hematology2,Hebei Petro China Central Hospital,Langfang 065000,Hebei,China)
关键词:
脾脏硬度; FibroScan; 流式细胞术; 急性髓系白血病; 微小残留病
Keywords:
Spleen stiffness measurement; FibroScan; Flow cytometry; Acute myeloid leukemia; Minimal residual disease
分类号:
R733.71
DOI:
10.3969/j.issn.1006-1959.2022.05.031
文献标志码:
A
摘要:
目的 探讨脾脏硬度（SSM）联合流式细胞术（FCM）在急性髓系白血病（AML）微小残留病（MRD）监测中的意义。方法 选取2016年3月-2020年3月在河北中石油中心医院就诊的33例初治AML患者，治疗前作为初诊组、治疗后作为诱导化疗后组，同时选取15例健康志愿者作为对照组，分别进行SSM检测，比较各组SSM差异，进一步根据MRD水平将诱导化疗后患者分为MRD-、MRD+组，比较各组SSM差异，分析MRD+组SSM与MRD的相关性。结果 初诊组SSM高于对照组、诱导化疗后组，差异有统计学意义（P＜0.05）；MRD+组SSM高于MRD-组，差异有统计学意义（P＜0.05）；MRD+组SSM与MRD水平呈正相关（r=0.877）；7例患者复发时SSM升高，9例持续缓解患者SSM总体呈下降趋势。结论 诱导化疗后SSM与MRD密切相关，用FS检测SSM或可联合FCM检测MRD对AML患者进行动态随访、评估预后。
Abstract:
Objective To explore the role of spleen stiffness measurement (SSM) combine with flow cytometry (FCM) in acute myeloid leukemia (AML) minimal residual disease (MRD) monitoring.Methods From March 2016 to March 2020, 33 newly diagnosed AML patients in Hebei Petro China Central Hospital were selected. Before treatment, they were taken as the initial diagnosis group, and after treatment, they were taken as the post-induction chemotherapy group. At the same time, 15 healthy volunteers were selected as the control group. SSM tests were performed to compare the differences of SSM in each group. The patients after induction chemotherapy were further divided into MRD- and MRD+ groups according to the MRD level. The differences of SSM in each group were compared, and the correlation between SSM and MRD in the MRD+ group was analyzed.Results The SSM of the initial diagnosis group was higher than that of the control group and the post-induction chemotherapy group, and the difference was statistically significant (P<0.05). The SSM in the MRD+ group was higher than that in the MRD- group, and the difference was statistically significant (P<0.05). SSM in MRD+ group was positively correlated with MRD level (r=0.877); SSM increased in 7 patients with recurrence, and decreased in 9 patients with continuous remission.Conclusion Post-induction chemotherapy SSM was strongly correlated with MRD. Combined SSM detection by using FS with MRD detection by using FCM may be used to follow up AML patients, to assess the prognosis.

参考文献/References:

[1]岳文勤,唐古生,柳敏,等.CD123在急性髓系白血病患者骨髓异常细胞群中的表达及预后价值[J].中华血液学杂志,2017,38(10):876-882.[2]Bumeu A,Wetzler M,Lowenberg B.Therapeutic advances in acute myeloid leukemia[J].J Clin Oncol,2011,29(5):487-494.[3]Uras IZ,Maurer B,Nebenfuehr S,et al.Therapeutic Vulnerabilities in FLT3-Mutant AML Unmasked by Palbociclib[J].Int J Mol Sci,2018,19(12):3987.[4]Lee DJ,Zeidner JF.Cyclin-dependent kinase (CDK) 9 and 4/6 inhibitors in acute myeloid leukemia (AML): a promising therapeutic approach[J].Expert Opin Investig Drugs,2019,28(11):989-1001.[5]Ossenkoppele G,Schuurhuis GJ,van de Loosdrecht A,et al.Can we incorporate MRD assessment into clinical practice in AML?[J].Best Pract Res Clin Haematol,2019,32(2):186-191.[6]Oliveri F,Coco B,Ciccorossi P,et al.Liver stiffness in the hepatitis B virus carrier: a non -invasive marker of liver disease influenced by the pattern of transaminases[J].World J Gastroenterol,2008,14(40):6154-6162.[7]Sintusek P,Siriporn N,Punpanich D,et al.Spleen and Liver Stiffness to Detect Esophageal Varices in Children with Biliary Atresia[J].J Pediatr Gastroenterol Nutr,2019,69(4):411-415.[8]Iurlo A,Cattaneo D,Giunta M,et al.Reply To: Assessment of Liver and Spleen Stiffness in Patients With Myelofibrosis Using FibroScan and Shear Wave Elastography[J].Ultrasound Q,2016,32(3):317.[9]Saito H,Tada S,Nakamoto N,et al.Efficacy of non-invasive elastometry on staging of hepatic fibrosis[J].Hepatol Res,2004,29(2):97-103.[10]Sharma P,Kirnake V,Tyagi P,et al.Spleen Stiffness in Patients With Cirrhosis in Predicting Esophageal Varices[J].Am J Gastroenterol,2013,108(7):1101-1107.[11]Liu FJ,Cheng WY,Lin XJ,et al.Measurable Residual Disease Detected by Multiparameter Flow Cytometry and Sequencing Improves Prediction of Relapse and Survival in Acute Myeloid Leukemia[J].Front Oncol,2021,20(11):677833.[12]Tsai CH,Tang JL,Tien FM,et al.Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML[J].Blood Adv,2021,5(10):2456-2466.[13]Buechter M,Manka P,Theysohn JM,et al.Spleen stiffness is positively correlated with HVPG and decreases significantly after TIPS implantation[J].Dig Liver Dis,2018,50(1):54-60.[14]Marasco G,Colecchia A,Colli A,et al.Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection[J].J Hepatol,2019,70(3):440-448.[15]San Miguel JF,Vidriales MB,López-Berges C,et al.Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patients risk groups and may contribute to postinduction treatment stratification[J].Blood,2001,98(6):1746-1751.[16]Buccisano F,Hourigan CS,Walter RB.The Prognostic Significance of Measurable("Minimal") Residual Disease in Acute Myeloid Leukemia[J].Curr Hematol Malig Rep,2017,12(6):547-556.

相似文献/References:

[1]赵崇山,王宁方,何文艳.脾脏硬度及细胞因子在原发性血小板增多症患者血栓预测中的价值[J].医学信息,2021,34(21):69.[doi:10.3969/j.issn.1006-1959.2021.21.017]
　ZHAO Chong-shan,WANG Ning-fang,HE Wen-yan.The Value of Spleen Stiffness Measurement and Cytokines in Predicting Thrombosis in Patients with Essential Thrombocytosis[J].Medical Information,2021,34(05):69.[doi:10.3969/j.issn.1006-1959.2021.21.017]
[2]赵崇山,王宁方.脾脏硬度对初发骨髓增生异常综合征患者预后的影响[J].医学信息,2022,35(07):88.[doi:10.3969/j.issn.1006-1959.2022.07.021]
　ZHAO Chong-shan,WANG Ning-fang.Effect of Spleen Stiffness Measurement on Prognosis of Patients with Primary Myelodysplastic Syndrome[J].Medical Information,2022,35(05):88.[doi:10.3969/j.issn.1006-1959.2022.07.021]

更新日期/Last Update: 1900-01-01